ERBB2 and neoplasm: For example, the diagnostic potential of TEPs was determined by mRNA sequencing, which could distinguish tumor patients from healthy individuals with 96% accuracy, correctly identified across six different tumor types with 71% accuracy, and also ascertain MET- or HER2-positive and mutant KRAS, EGFR, or PIK3CA tumors (48).